The British Journal of Ophthalmology, published by the BMJ Publishing Group, stands as a leading peer-reviewed journal in the field of ocular sciences, with a distinctive focus on advancing the understanding of vision and its impairment. With a rich history dating back to 1941, this journal serves as an essential platform for researchers, professionals, and students in ophthalmology and related disciplines. It prominently ranks in the Q1 quartile for Ophthalmology and Cellular and Molecular Neuroscience in 2023, reflecting its esteemed reputation in the scientific community. The journal boasts impressive Scopus rankings, including Rank #6 in Medicine - Ophthalmology, showcasing its influential contributions to the field. Although it does not offer open access, the journal is committed to disseminating high-quality research that informs clinical practices and enriches the understanding of sensory systems. Submissions are encouraged from all areas of ophthalmology, including clinical studies, innovative research, and systemic reviews. Join the vibrant academic dialogue by engaging with the cutting-edge findings published in the British Journal of Ophthalmology, which aims to bridge the gap between research and clinical application.

Translational Vision Science & Technology is a premier open access journal dedicated to the advancement of the field of ophthalmology and biomedical engineering. Published by the Association for Research in Vision and Ophthalmology, Inc., this journal has established itself as a leading source of high-quality research since its inception in 2013, achieving a remarkable impact factor reflective of its influential contribution to the field. With an impressive ranking of #21 in Ophthalmology and #120 in Biomedical Engineering within the Scopus database, it sits within the prestigious Q1 quartile for both categories as of 2023, further validating its significance. The journal's scope encompasses a wide variety of topics focused on the intersection of ophthalmological science and technological innovation, welcoming contributions that promote the understanding and treatment of visual disorders. Available as an Open Access publication since 2016, it ensures that cutting-edge research is freely accessible to researchers, practitioners, and students worldwide, facilitating the rapid dissemination of knowledge essential for the advancement of vision science.

OPHTHALMOLOGICA is a prestigious journal published by KARGER, dedicated to the dynamic field of ophthalmology and its interdisciplinary connections with medicine and sensory systems. With a rich history spanning over a century since its inception in 1899, this journal is esteemed for its high-quality research and impactful contributions, maintaining an impressive Q1 quartile ranking in both ophthalmology and miscellaneous medicine as of 2023, alongside a notable Q2 status in sensory systems. The journal's influence is reinforced by its Scopus rankings, where it ranks 26th out of 137 in ophthalmology, showcasing a strong percentile position of 81. Based in Basel, Switzerland, OPHTHALMOLOGICA serves as an essential platform for researchers, professionals, and students, providing essential insights, reviews, and studies that push the boundaries of knowledge in the vision sciences. Although it does not currently offer open access, its contributions are critical for those pursuing advancements in ocular health and related disciplines.

CURRENT EYE RESEARCH is a prestigious academic journal published by Taylor & Francis Inc, focusing on advancing the field of ophthalmology and its intersection with cellular and molecular neuroscience. Since its inception in 1981, this journal has provided a vital platform for original research, reviews, and technical notes, presenting a wealth of knowledge to practitioners and researchers alike. With an impressive 2023 impact factor reflected in its ranking of Q2 in Ophthalmology and Q2 in Sensory Systems, and a Q3 ranking in Cellular and Molecular Neuroscience, CURRENT EYE RESEARCH plays a crucial role in fostering interdisciplinary collaboration and innovation. The journal is indexed in Scopus, where it holds strong positions in both the Medicine and Neuroscience categories, enhancing its visibility and reach. Researchers and professionals in these fields can access cutting-edge findings and contribute to the ongoing discourse surrounding eye health, making it an essential resource for anyone invested in advancing knowledge and treatment in ophthalmic science.

Asia-Pacific Journal of Ophthalmology is a distinguished open access journal published by the Asia-Pacific Academy of Ophthalmology (APAO), specializing in the latest advancements and research in ophthalmology. Since its inception in 2013, this journal has established itself as a vital platform for disseminating innovative findings and clinical practices across the Asia-Pacific region and beyond. With an impressive Scopus ranking of #10 out of 137 in the field of Medicine (Ophthalmology), placing it in the 93rd percentile, it garners significant attention and respect within the academic community. Currently holding a Q1 categorization in both Medicine (miscellaneous) and Ophthalmology, the journal embraces a broad scope that encompasses clinical studies, experimental research, and reviews aimed at enhancing the understanding and management of eye health. Its open access model since 2019 ensures that all published works are freely accessible, promoting greater collaboration and knowledge sharing among researchers, clinicians, and students. Situated in the Netherlands with a prominent address in Hong Kong, the journal serves as an essential resource for anyone dedicated to the field of ophthalmology.

SURVEY OF OPHTHALMOLOGY is a premier journal published by Elsevier Science Inc, dedicated to advancing knowledge in the field of ophthalmology. With an impact factor reflective of its high-quality research—ranking 7th out of 137 in the Scopus category for medicine and ophthalmology, this journal maintains a prestigious Q1 categorization in its field for 2023. Since its inception in 1956, the journal has provided comprehensive reviews and original articles covering various aspects of ophthalmic research and clinical practice, supporting the ongoing education of researchers, professionals, and students alike. While open access options are not available, the journal remains an essential resource for the latest developments, discoveries, and expert insights that shape the future of eye health. Based in the United States, at STE 800, 230 Park Ave, New York, NY 10169, the journal continues a legacy of excellence in ophthalmology until 2024 and beyond, making it a pivotal element of scholarly discourse in this vital medical discipline.

Ophthalmic Surgery Lasers & Imaging Retina is a distinguished journal dedicated to the dissemination of cutting-edge research and clinical advancements in the fields of ophthalmology, surgery, and the application of lasers in retinal care. Published by SLACK INC since its inception in 2013, this journal operates without an open access model, catering primarily to a scholarly audience seeking in-depth and impactful studies. With an impressive impact factor and categorized within the Q2 quartile in respective fields for 2023, it features contributions that significantly enhance the understanding and treatment of ocular diseases. The journal's robust editorial board ensures that only rigorous and innovative research is presented, making it a vital resource for researchers, healthcare professionals, and students who aim to stay at the forefront of ophthalmic surgery and imaging techniques. It continues to forge a path for collaboration and knowledge sharing within the global ophthalmology community.

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is a leading peer-reviewed journal published by Wiley, renowned for its commitment to advancing the field of ophthalmology. With an impressive impact factor reflecting its high-quality research contributions, this journal is ranked in the Q1 category both in Medicine (miscellaneous) and Ophthalmology, signifying its crucial role in shaping contemporary ophthalmic research. It boasts a remarkable position in the Scopus Ranks, standing at Rank #13 out of 137 in the field of Medicine and Ophthalmology, placing it within the 90th percentile among its peers. Having been in circulation since 1979, this journal encompasses a broad scope of topics that aim to disseminate groundbreaking findings and stimulate dialogue among researchers, clinicians, and students alike. It is easily accessible to a global audience, embodying the principles of open access, making valuable research available to all. For anyone seeking to stay at the forefront of ophthalmology, CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is an indispensable resource that fosters knowledge and innovation in the ever-evolving landscape of eye care.

ARQUIVOS BRASILEIROS DE OFTALMOLOGIA is a prominent peer-reviewed journal dedicated to the field of ophthalmology, published by CONSEL BRASIL OFTALMOLOGIA since its inception in 1945. With its commitment to disseminating high-quality research, the journal has transitioned to an Open Access model since 2001, ensuring that vital findings in ophthalmology are freely available to researchers, clinicians, and students alike. Located in São Paulo, Brazil, this esteemed publication occupies a significant position in the medical field, currently holding a Q3 ranking in both the miscellaneous medicine and ophthalmology categories. Although it maintains a legacy of fluctuating impact, recognized for its contribution to the academic community, ARQUIVOS BRASILEIROS DE OFTALMOLOGIA continues to attract a diverse international readership, making it a valuable resource for advancements in eye health, surgical techniques, and ocular research.

Canadian Journal of Ophthalmology - Journal Canadien d'Ophtalmologie, published by the prestigious Canadian Ophthalmological Society, serves as a leading platform for disseminating cutting-edge research in the field of ophthalmology. With an ISSN of 0008-4182 and E-ISSN 1715-3360, the journal boasts a commendable impact factor and maintains a strong presence within the medicine and ophthalmology categories, ranking in the Q2 quartile. This journal not only provides significant insights into clinical practices and advancements but also contributes to the understanding of ocular health issues facing contemporary society. Since its inception in 1966, it has published high-quality research, making substantial strides in both practical and theoretical aspects of ophthalmology until 2024. Although it is not an open-access journal, it establishes a vital resource for researchers, professionals, and students alike, fostering an informed community dedicated to improving vision care.